PRT12396

· Prelude Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRT12396, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms [Phase 1]